Clinical Trial

CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II

Study acronym: CIRCULATE
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The objective of CIRCULATE trial is to improve care of patients after colon tumor surgery, based on an innovative marker: circulating tumor DNA.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-10-08; most recent amendment 2026-07-09.
Status change: Not Yet Recruiting → Recruiting 2021-10-21
Trial Details
NCT Number NCT04120701
Lead Sponsor Centre Hospitalier Universitaire Dijon
Conditions Patients With Resected Stage II Colon Cancer
Enrollment 1,980 participants
Start Date 2020-01-17
Primary Completion 2032-03 (estimated)
Study Completion 2032-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-10